Navigation Links
Join NPR's David Ewing Duncan, Author Jessica Queller and a Panel of Medical and Legal Experts in a 90-Minute Webcast on Genetic Testing, Genomic Medicine and Breast & Ovarian Cancer
Date:5/19/2008

GREENWICH, Conn., May 19 /PRNewswire/ -- Helix Health, the first U.S. stand-alone genomic medicine practice, is hosting a 90-minute webcast this Wednesday, May 21, 2008 from 1:00-2:30 PM EDT examining:
How Genomic Medicine Is Changing the Management of Breast & Ovarian Cancer

To register, point your browser here http://event.netbriefings.com/event/helixhealth/register.html .

Every hour, 150 people in the United States are diagnosed with cancer. There is a growing number of people who are not willing to wait for that diagnosis. They are undergoing genetic testing to discover, and to know what they must do to manage these risks... personalized medicine for effective heath care management.

Topics:

What should a doctor and patient do when a patient tests positive?

What is the risk in taking a "wait and see" approach?

Are there alternatives to radical surgery?

What are potential tort issues in predictive genetic testing and medical

uses of genetic tests?

Panel:

Steven A.R. Murphy, MD - Clinical Genetics Fellow at Yale School of

Medicine, and Helix Health's Managing Partner will moderate the panel.

Barbara A. Ward, MD - Director, The Breast Center of Greenwich Hospital;

principal investigator of the STAR Trial

http://www.ynhh.org/healthlink/cancer/cancer_7_99.html; surgical

oncologist affiliated with Yale-New Haven Health System.

Jessica Queller - author of Pretty Is What Changes; television writer for

Felicity, The Gilmore Girls and One Tree Hill. Writer/producer on Gossip

Girl.

Jennifer Ibrahim, MD - clinical geneticist specializing in preconception

genetics as well as familial cancer syndromes.

David Ewing Duncan - bestselling author of Masterminds: Genius, DNA and

the Quest to Rewrite Life; Director, Center for Life Sciences Policy, UC

Berkeley; Chief Correspondent and co-host of National Public Radio's

"Biotech Nation".

Gary E. Marchant - Ph.D. J.D., Lincoln Professor of Emerging

Technologies, Law & Ethics, Sandra Day O'Connor College of Law; Executive

Director, Center for Law, Science & Technology, Professor, School of Life

Sciences Arizona State University.

Registration

To register, point your browser here http://event.netbriefings.com/event/helixhealth/register.html

Registration is limited, so please register soon.

If you are unable to attend, a podcast of the session will soon be available on the Helix Health website. http://www.helixhealth.org/

About Helix Health, PLLC/LLC - a medical practice that is bringing genomic medicine to health care. With offices in Greenwich, CT and New York, NY, Helix Health offers patients and their physicians expertise in genomic medicine and provides the tools required to take full advantage of genetic testing.

Contact info@helixhealth.org for more information, or visit http://www.helixhealth.org/


'/>"/>
SOURCE Helix Health
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. InterMune Announces Approval of Clinical Trial Authorization for Phase 1b Trial of ITMN-191
2. FDA Advisory Committees Recommend Continued U.S. Marketing Authorization for Trasylol(R)
3. Authorization for AGENDA Phase 3 Trial of Genasense(R) in Advanced Melanoma Granted by French Regulatory Agency
4. Anpath Group, Inc. Announces Selection of its Disinfectant by the Washington Metropolitan Area Transit Authority (Metro)
5. Pharmion Submits European Marketing Authorization Application (MAA) for Vidaza(R) in Patients with Higher-Risk Myelodysplastic Syndromes (MDS)
6. Cell Therapeutics, Inc. (CTI) Submits European Marketing Authorization Application for XYOTAX(TM)
7. European Regulatory Agency Accepts Cell Therapeutics, Inc.s Marketing Authorization Application for XYOTAX(TM) for Lung Cancer for Review
8. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
9. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
10. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
11. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/7/2017)... Aug. 7, 2017  Diplomat Pharmacy, Inc. (NYSE: DPLO), the ... quarter ended June 30, 2017.  All comparisons, unless otherwise noted, ... Second Quarter 2017 Highlights include: ... $1,089 million, an increase of 3.5% Total ... Gross margin of 7.5% versus 7.6% ...
(Date:8/3/2017)... 2017  Opioid addiction and other drugs of abuse, ... and threatening outcomes, were problems taken on directly as ... that support them, met this week. This according to ... drugs of abuse, procalcitonin and acute kidney injury were ... 69th meeting in San Diego, CA. ...
(Date:8/2/2017)... CaryRx, a next-generation full-service pharmacy, has announced the ... in the Washington D.C. metropolitan area. ... delivery of medications through the convenience of its patient-friendly mobile ... within one hour to any location in D.C. ... invaluable service to Washington D.C. ," says ...
Breaking Medicine Technology:
(Date:8/18/2017)... ... August 18, 2017 , ... August ... “Vision & Hearing,” advocating for active, healthy lifestyles and highlighting the importance of ... individuals with hearing impairments and shares the latest innovations in hearing aid technology. ...
(Date:8/18/2017)... ... August 18, 2017 , ... The Dawn Johnson Insurance Group, a ... charity drive to generate community support for efforts to educate the local population on ... for all types of cancer. , Each day in America, roughly 4,600 new ...
(Date:8/18/2017)... ... August 18, 2017 , ... Moore Insurance, a ... in east Texas, is launching a regional charity effort to provide publicity assistance ... the Pediatric Brain Tumor Foundation (PBTF) has raised nearly $30 million in donations ...
(Date:8/18/2017)... TX (PRWEB) , ... August 18, 2017 , ... ... management and financial planning firm that serves residential and commercial clients in the ... charity drive to raise community support for the fight against cancer. , Founded ...
(Date:8/18/2017)... ... August 18, 2017 , ... With over 16,000 active ... hormone replacement therapy and integrative medicine, has become a frontrunner for people seeking ... as menopause, andropause, thyroid disorder and adrenal insufficiencies. , Founded in 2003 ...
Breaking Medicine News(10 mins):